Project data
Funding Entity: European Commission
Call: H2020-SC1-FA-DTS-2018-2020
Coordinator: HELSINGIN YLIOPISTO ( Finland)
UNISI Principal Investigator: Alessandra Renieri
Department: DEPT. MEDICAL BIOTECHNOLOGIES
Start date: 1 January 2021 – End date: 31 December 2025
Description
Different people develop disease and respond to treatments differently. Moving away from the one-size-fits-all approach, personalised medicine pursues treatment options tailored to the genetic profile of individuals. The EU-funded INTERVENE project will develop next-generation tools for disease prevention, diagnosis and personalised treatment. INTERVENE will use powerful artificial intelligence technologies on a vast and diverse US-European pool of genomic and health data to calculate genetic risk scores that predict an individual’s susceptibility to a particular disease. The risk scores will be tested in clinical trials focusing on devastating common diseases, such as diabetes, cancer, and cardiovascular disease. INTERVENE will also develop and test the role of risk scores in several rare diseases as well as COVID-19 infection and severity.
Source: Cordis
This project has received funding from the European Union’s Horizon 2020 programme under GA No 101016775